Caroline Grygar

1.3k total citations
12 papers, 1.0k citations indexed

About

Caroline Grygar is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Caroline Grygar has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Caroline Grygar's work include Immunotherapy and Immune Responses (8 papers), Immune Response and Inflammation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Caroline Grygar is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Response and Inflammation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Caroline Grygar collaborates with scholars based in France, Switzerland and Germany. Caroline Grygar's co-authors include Chrystelle Brignone, Frédéric Triebel, Manon Marcu, David Leppert, Karen Miller, Stephen L. Leib, U. B. Schaad, Georg A. Holländer, Bernard Escudier and Hanno Langen and has published in prestigious journals such as Journal of Clinical Oncology, Nature Immunology and The Journal of Immunology.

In The Last Decade

Caroline Grygar

11 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Caroline Grygar	566	517	179	104	86	12	1.0k
Amanda M. Burkhardt	477 0.8×	469 0.9×	365 2.0×	72 0.7×	109 1.3×	20	1.1k
Mahyar Nouri‐Shirazi	1.3k 2.3×	476 0.9×	543 3.0×	95 0.9×	108 1.3×	26	1.9k
Clemens Esche	1.0k 1.8×	587 1.1×	415 2.3×	121 1.2×	110 1.3×	34	1.5k
Koenraad Gijbels	550 1.0×	237 0.5×	298 1.7×	420 4.0×	89 1.0×	10	1.4k
Ana Clara Marques Davalos‐Misslitz	1.0k 1.8×	536 1.0×	280 1.6×	48 0.5×	123 1.4×	10	1.5k
Robert Tacke	682 1.2×	269 0.5×	241 1.3×	85 0.8×	138 1.6×	14	1.0k
Steve P. Crampton	373 0.7×	131 0.3×	399 2.2×	74 0.7×	53 0.6×	14	911
Marleen Ansems	365 0.6×	210 0.4×	264 1.5×	115 1.1×	54 0.6×	38	835
Jiang-Hong Gong	882 1.6×	560 1.1×	211 1.2×	54 0.5×	165 1.9×	12	1.2k
Jason G. Cyster	808 1.4×	455 0.9×	217 1.2×	40 0.4×	94 1.1×	6	1.1k

Countries citing papers authored by Caroline Grygar

Since Specialization

Citations

This map shows the geographic impact of Caroline Grygar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Grygar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Grygar more than expected).

Fields of papers citing papers by Caroline Grygar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Grygar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Grygar. The network helps show where Caroline Grygar may publish in the future.

Co-authorship network of co-authors of Caroline Grygar

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Grygar. A scholar is included among the top collaborators of Caroline Grygar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Grygar. Caroline Grygar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lallemand, Christophe, et al.. (2025). Advanced assay platform for antibody development: Precision assays for ADCC, ADCP, and CDC. Immunobiology. 230(4). 152948–152948.

Castelli, Florence, Natacha Szely, Nicoletta Casartelli, et al.. (2013). Hierarchy of CD4 T Cell Epitopes of the ANRS Lipo5 Synthetic Vaccine Relies on the Frequencies of Pre-Existing Peptide-Specific T Cells in Healthy Donors. The Journal of Immunology. 190(11). 5757–5763. 18 indexed citations

Brignone, Chrystelle, Maya Gutierrez, F. Mefti, et al.. (2010). First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity. Journal of Translational Medicine. 8(1). 71–71. 202 indexed citations

Brignone, Chrystelle, Bernard Escudier, Caroline Grygar, Manon Marcu, & Frédéric Triebel. (2009). A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma. Clinical Cancer Research. 15(19). 6225–6231. 178 indexed citations

Triebel, Frédéric, et al.. (2008). IMP321 and weekly paclitaxel as first-line chemoimmunotherapy for metastatic breast cancer (MBC). Journal of Clinical Oncology. 26(15_suppl). 1045–1045. 4 indexed citations

Brignone, Chrystelle, Caroline Grygar, Manon Marcu, Knut Schäkel, & Frédéric Triebel. (2007). A Soluble Form of Lymphocyte Activation Gene-3 (IMP321) Induces Activation of a Large Range of Human Effector Cytotoxic Cells. The Journal of Immunology. 179(6). 4202–4211. 60 indexed citations

Brignone, Chrystelle, Caroline Grygar, Manon Marcu, Gaëlle Perrin, & Frédéric Triebel. (2007). IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study. Vaccine. 25(24). 4641–4650. 32 indexed citations

Brignone, Chrystelle, Caroline Grygar, Manon Marcu, Gaëlle Perrin, & Frédéric Triebel. (2007). IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study. PubMed. 5(1). 5–5. 30 indexed citations

Constantinescu, Cris S., Caroline Grygar, Ludwig Kappos, & David Leppert. (2001). INTERLEUKIN 15 STIMULATES PRODUCTION OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 BY HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS. Cytokine. 13(4). 244–247. 28 indexed citations

10.

Kropshofer, Harald, Sebastian Spindeldreher, Till A. Röhn, et al.. (2001). Tetraspan microdomains distinct from lipid rafts enrich select peptide–MHC class II complexes. Nature Immunology. 3(1). 61–68. 180 indexed citations

11.

Leppert, David, Stephen L. Leib, Caroline Grygar, et al.. (2000). Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae. Clinical Infectious Diseases. 31(1). 80–84. 216 indexed citations

12.

Leppert, David, P. Hughes, S. J. Huber, et al.. (1999). Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology. 53(1). 62–62. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact